Share this initiative
Sharpen® is deployed via web-based SaaS across health systems, schools, and community organizations. Administrators configure population-specific toolkits; users access screening, psychoeducation, and crisis resources on any device.
Our digital therapeutic interventions are appropriate for children ages 9 and up who speak English and Spanish
Sharpen® DTX can serve adolescents through peer-focused documentary style interventions
Adults can benefit from the Sharpen® DTX system
Now accepting submissions of interest for the upcoming issue.
Interconnected is the world’s only digital mental health magazine.
Want to be featured?
Email [email protected]
Despite growing investment in mental health apps and digital tools, most people in crisis never access care due to lack of access. Existing solutions require a separate app to download, a portal to log into, a referral to follow up on. These fragmented systems force individuals to self-navigate across screening, education, and crisis support, often failing at each transition.
Sharpen® addresses this gap directly by integrating behavioral health screening, mental health literacy, and crisis resources into a single, seamless platform that meets people where they are.
Sharpen® is built on a foundation that includes 20 years of community-based participatory research across underserved and underrepresented populations, including foster youth and veterans. As a federally certified Woman-Owned Small Business (WOSB), Resiliency Technologies is committed to equity-centered design at every level.
The platform supports English and Spanish, with additional language expansion underway. Sharpen® is EHR-interoperable and designed for reimbursement pathways. Our documentary film intervention methodology achieves a 92% completion rate, far exceeding industry norms for digital health engagement.
Sharpen® is a digital therapeutics platform and clinical decision support system delivering integrated mental health care from early literacy to crisis intervention. Powered by CAT-MH® adaptive screening, it provides real-time acuity scoring across depression, anxiety, suicide risk, and substance use.
Clinicians receive immediate, actionable triage data enabling same-day intervention for highest-risk individuals. Population-specific toolkits deploy across health systems, universities, athletic programs, and medical schools — combining screening, psychoeducation, and crisis resources in one seamless experience. Currently in active clinical trials at Stanford University, UCSF, and Prisma Health Children’s Hospital, Sharpen® closes the gap between identification and care.
Three ways to get involved:
Choose the level that fits.
